Molina Healthcare (NYSE:MOH) updated its FY20 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $11.20-11.70 for the period, compared to the Thomson Reuters consensus estimate of $12.07. The company issued revenue guidance of $18.8 billion, compared to the consensus revenue estimate of $19.00 billion.Molina Healthcare also updated its FY 2020
After-Hours guidance to 11.20-11.70 EPS.
A number of research firms recently commented on MOH. Cfra upgraded Molina Healthcare from a hold rating to a buy rating and lifted their price target for the stock from $141.00 to $191.00 in a research note on Monday, May 4th. ValuEngine downgraded Molina Healthcare from a hold rating to a sell rating in a research note on Thursday, June 4th. Deutsche Bank decreased their price target on Molina Healthcare from $206.00 to $188.00 and set a buy rating for the company in a research note on Monday, May 4th. Morgan Stanley lifted their price target on Molina Healthcare from $175.00 to $229.00 and gave the stock an overweight rating in a research note on Friday, May 15th. Finally, SVB Leerink assumed coverage on Molina Healthcare in a research note on Wednesday, July 1st. They issued an outperform rating and a $220.00 price target for the company. One investment analyst has rated the stock with a sell rating, three have issued a hold rating and eleven have assigned a buy rating to the company’s stock. The company currently has a consensus rating of Buy and a consensus target price of $190.57.
MOH stock traded down $2.32 during midday trading on Friday, reaching $184.70. The company had a trading volume of 614,272 shares, compared to its average volume of 294,999. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 1.11. The stock has a 50 day moving average price of $178.99 and a 200 day moving average price of $157.50. The firm has a market capitalization of $10.93 billion, a PE ratio of 14.22, a P/E/G ratio of 1.73 and a beta of 0.70. Molina Healthcare has a fifty-two week low of $102.85 and a fifty-two week high of $196.52.
In other news, Director Steven J. Orlando sold 1,718 shares of the business’s stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $179.38, for a total transaction of $308,174.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Garrey Carruthers sold 1,700 shares of the business’s stock in a transaction that occurred on Wednesday, May 6th. The stock was sold at an average price of $183.46, for a total value of $311,882.00. The disclosure for this sale can be found here. Insiders own 1.07% of the company’s stock.
About Molina Healthcare
Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.
See Also: Should You Consider an Index Fund?
Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.